SCHEMBL9508265

SCHEMBL9508265

Cc1ccccc1Nc1nc(N(C)c2ccccc2)c2cccc(O)c2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9508893 0.87
Bromide SCHEMBL9510888 0.86
Hydrochloric Acid SCHEMBL9776665 0.85
SCHEMBL9508894 0.84
Hydrochloric Acid SCHEMBL9776709 0.83
SCHEMBL9776705 0.83 NPC1 (0.59)
Hydrochloric Acid SCHEMBL9776836 0.82 NPC1 (0.61)
Hydrochloric Acid SCHEMBL9776921 0.82 NPC1 (0.61)
SCHEMBL9508929 0.81
Hydrochloric Acid SCHEMBL9776694 0.79 NPC1 (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0404322-B1 QUINAZOLINE DERIVATIVES SMITHKLINE BEECHAM INTERCREDIT B.V. (NL) 1993-09-22 EP claimed
US-5064833-A Substituted quinazoline derivatives for use in gastrointestinal diseases SMITHKLINE BEECHAM INTERCREDIT B.V. (GB) 1991-11-12 US claimed
EP-0404322-A1 Quinazoline derivatives SMITHKLINE BEECHAM INTERCREDIT B.V. (NL) 1990-12-27 EP claimed
JP-3017068-A None JP disclosed
EP-0404322-B1 QUINAZOLINE DERIVATIVES SMITHKLINE BEECHAM INTERCREDIT B.V. (NL) 1993-09-22 EP disclosed
US-5064833-A Substituted quinazoline derivatives for use in gastrointestinal diseases SMITHKLINE BEECHAM INTERCREDIT B.V. (GB) 1991-11-12 US disclosed
JP-H0317068-A SUBSTITUTED QUAINAZOLINE DERIVATIVE SMITHKLINE BEECHAM INTERCREDIT BV 1991-01-25 JP disclosed
EP-0404322-A1 Quinazoline derivatives SMITHKLINE BEECHAM INTERCREDIT B.V. (NL) 1990-12-27 EP disclosed